Viewing StudyNCT04900454



Ignite Creation Date: 2024-05-06 @ 4:12 PM
Last Modification Date: 2024-10-26 @ 2:05 PM
Study NCT ID: NCT04900454
Status: COMPLETED
Last Update Posted: 2024-04-08
First Post: 2021-05-20

Brief Title: Allogeneic Natural Killer NK Cell Therapy in Subjects Hospitalized for COVID-19
Sponsor: Coeptis Therapeutics
Organization: Coeptis Therapeutics

Organization Data

Organization: Coeptis Therapeutics
Class: INDUSTRY
Study ID: DVX201-COV-01
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Coeptis Therapeutics
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Fred Hutchinson Cancer Center OTHER